Co-treatment with metformin, TRAIL, and ATG5siRNA-1 significantly increased the cell viability of lung adenocarcinoma A549 cells with decreased cell death (Figure 5B, 5C and 5D). This evidence concerns the gene TNFSF10 and lung adenocarcinoma.